China’s WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to US drug maker Merck & Co for about US$500 million, ahead of potential US legislation that would restrict ...

WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 for the Chinese biotech and drug companies after the US Biosecure legislation that threatened to cut them out from ...

the Hang Seng China Enterprise ETF, Wuxi Biologics, Tencent, China National Petroleum, and Semiconductor Manufacturing International (SMIC). Shanghai, Shenzhen, and the STAR Board diverged to ...

The sale will allow the company to realize its investment in the assets and focus on providing contract vaccine services from its sites in Suzhou, China, WuXi Biologics said in the filing.

Jan 6 (Reuters) - China's WuXi Biologics (2269.HK), opens new tab said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co (MRK.N), opens new tab for about $500 ...